Stifel Nicolaus Raises Guardant Health (NASDAQ:GH) Price Target to $53.00

Guardant Health (NASDAQ:GH – Get Free Report) had its target price hoisted by stock analysts at Stifel Nicolaus from $45.00 to $53.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ target price suggests a potential upside of 23.63% from the company’s current […]

Leave a Reply

Your email address will not be published.

Previous post New York State Teachers Retirement System Sells 1,443 Shares of Tripadvisor, Inc. (NASDAQ:TRIP)
Next post HC Wainwright Reiterates Buy Rating for Prothena (NASDAQ:PRTA)